Daniel Farnum
Corporate Officer/Principal chez Humboldt Medical Group, Inc.
Profil
Daniel Farnum is currently a Co-Owner at Humboldt Medical Group, Inc. He was previously a Director at Iris BioTechnologies, Inc. Farnum received his undergraduate and doctorate degrees from The University of California, San Francisco.
Postes actifs de Daniel Farnum
| Sociétés | Poste | Début |
|---|---|---|
| Humboldt Medical Group, Inc. | Corporate Officer/Principal | 02/05/2011 |
Anciens postes connus de Daniel Farnum
| Sociétés | Poste | Fin |
|---|---|---|
| IRIS BIOTECHNOLOGIES, INC. | Directeur/Membre du Conseil | - |
Formation de Daniel Farnum
| The University of California, San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Iris BioTechnologies, Inc.
 Iris BioTechnologies, Inc. Medical SpecialtiesHealth Technology Iris Biotechnologies, Inc. is life sciences company focused on health care. It offers the best approach to the treatment of cancer and other diseases through actionable integration of molecular profiling in the clinical decision-making process. The Iris Nano-Biochip product pipeline include CancerChip, PrenatalChip, Integrated Blood Test, IVF applications, NeuroChip, MetabolicChip, CardioChip, and Chips for veterinary, agricultural, environmental, and other applications. The company was founded by Simon Chin on February 16, 1999 and is headquartered in Santa Clara, CA. | Health Technology |
| Humboldt Medical Group, Inc. |
